Citation 82657

ALVI,KA: PU,H: LUCHE,M: RICE,A: APP,H: MC MAHON,G: DARE,H: MARGOLIS,B:. (1999). ASTERRIQUINONES PRODUCED BY ASPERGILLUS CANDIDUS INHIBIT BINDING OF THE GRB-2 ADAPTER TO PHOSPHORYLATED EGF RECEPTOR TYROSINE KINASE.. 52(3)

Citation Details

Title	ASTERRIQUINONES PRODUCED BY ASPERGILLUS CANDIDUS INHIBIT BINDING OF THE GRB-2 ADAPTER TO PHOSPHORYLATED EGF RECEPTOR TYROSINE KINASE.
Authors	ALVI,KA: PU,H: LUCHE,M: RICE,A: APP,H: MC MAHON,G: DARE,H: MARGOLIS,B:
Year	1999
Volume	52
Issue	3

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Aspergillus candidus (HYPHOMYCETES)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ASTERRIQUINONE SU-5220,NEO:	None
2	PROTEIN TYROSINE PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTERRIQUINONE SU-5220,NEO:	STRONG ACTIVITY
3	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ASTERRIQUINONE SU-5228	None
4	PROTEIN TYROSINE PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTERRIQUINONE SU-5228	ACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ASTERRIQUINONE SU-5500	None
6	PROTEIN TYROSINE PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTERRIQUINONE SU-5500	EQUIVOCAL
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ASTERRIQUINONE SU-5503	None
8	PROTEIN TYROSINE PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTERRIQUINONE SU-5503	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ASTERRIQUINONE,ISO:	None
10	PROTEIN TYROSINE PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTERRIQUINONE,ISO:	STRONG ACTIVITY
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ASTERRIQUINONE SU-5501	None
12	PROTEIN TYROSINE PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTERRIQUINONE SU-5501	STRONG ACTIVITY
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ASTERRIQUINONE SU-5504	None
14	PROTEIN TYROSINE PHOSPHORYLATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTERRIQUINONE SU-5504	WEAK ACTIVITY

Show SPARQL Queries (1)